These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

727 related items for PubMed ID: 19616501

  • 21. Tumor immunity and prolonged survival following combined adenovirus-HSP72 and CEA-plasmid vaccination.
    Myers AL, Krewet JA, Shah MR.
    Vaccine; 2005 May 20; 23(27):3565-71. PubMed ID: 15855015
    [Abstract] [Full Text] [Related]

  • 22. Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine.
    Fei-fei G, Jian W, Feng X, Li-ping S, Quan-yun S, Jin-ping Z, Pu-yan C, Pei-hong L.
    Vaccine; 2008 Oct 16; 26(44):5590-4. PubMed ID: 18761388
    [Abstract] [Full Text] [Related]

  • 23. Multiple copies of a tumor epitope in a recombinant hepatitis B surface antigen (HBsAg) vaccine enhance CTL responses, but not tumor protection.
    Haigh O, Guo H, Edgtton K, Mather M, Herd KA, Tindle RW.
    Virology; 2007 Nov 25; 368(2):363-75. PubMed ID: 17689584
    [Abstract] [Full Text] [Related]

  • 24. Enhanced immunogenicity of peptide P277 by heat shock protein HSP65 vector carrying tandem repeats of P277 to prevent type 1 diabetes in NOD mice.
    Liang J, Aihua Z, Yu W, Jingjing L.
    Exp Clin Endocrinol Diabetes; 2008 Oct 25; 116(9):541-8. PubMed ID: 18473288
    [Abstract] [Full Text] [Related]

  • 25. Protection against measles virus-induced encephalitis by anti-mimotope antibodies: the role of antibody affinity.
    Olszewska W, Obeid OE, Steward MW.
    Virology; 2000 Jun 20; 272(1):98-105. PubMed ID: 10873752
    [Abstract] [Full Text] [Related]

  • 26. [Effect of the immune strategy based on BCG priming and Ag85A/GM-CSF DNA vaccine boosting in mice].
    Tang Q, Dou J, Zhao FS, Chu LL, Pan M, Wang YF.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jul 20; 23(7):591-4. PubMed ID: 17618574
    [Abstract] [Full Text] [Related]

  • 27. Protection of pigs against Taenia solium cysticercosis using recombinant antigen or in combination with DNA vaccine.
    Guo YJ, Sun SH, Zhang Y, Chen ZH, Wang KY, Huang L, Zhang S, Zhang HY, Wang QM, Wu D, Zhu WJ.
    Vaccine; 2004 Sep 28; 22(29-30):3841-7. PubMed ID: 15364430
    [Abstract] [Full Text] [Related]

  • 28. A modified epitope identified for generation and monitoring of PSA-specific T cells in patients on early phases of PSA-based immunotherapeutic protocols.
    Lundberg K, Roos AK, Pavlenko M, Leder C, Wehrum D, Guevara-Patiño J, Andersen RS, Pisa P.
    Vaccine; 2009 Mar 04; 27(10):1557-65. PubMed ID: 19171173
    [Abstract] [Full Text] [Related]

  • 29. alpha-Fetoprotein-specific tumor immunity induced by plasmid prime-adenovirus boost genetic vaccination.
    Meng WS, Butterfield LH, Ribas A, Dissette VB, Heller JB, Miranda GA, Glaspy JA, McBride WH, Economou JS.
    Cancer Res; 2001 Dec 15; 61(24):8782-6. PubMed ID: 11751399
    [Abstract] [Full Text] [Related]

  • 30. Vaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer.
    Kim S, Lee JB, Lee GK, Chang J.
    Prostate; 2009 Jun 15; 69(9):938-48. PubMed ID: 19267351
    [Abstract] [Full Text] [Related]

  • 31. Comparison of two cancer vaccines targeting tyrosinase: plasmid DNA and recombinant alphavirus replicon particles.
    Goldberg SM, Bartido SM, Gardner JP, Guevara-Patiño JA, Montgomery SC, Perales MA, Maughan MF, Dempsey J, Donovan GP, Olson WC, Houghton AN, Wolchok JD.
    Clin Cancer Res; 2005 Nov 15; 11(22):8114-21. PubMed ID: 16299244
    [Abstract] [Full Text] [Related]

  • 32. DNA vaccination with CCL2 DNA modified by the addition of an adjuvant epitope protects against "nonimmune" toxic renal injury.
    Zheng G, Wang Y, Xiang SH, Tay YC, Wu H, Watson D, Coombes J, Rangan GK, Alexander SI, Harris DC.
    J Am Soc Nephrol; 2006 Feb 15; 17(2):465-74. PubMed ID: 16396966
    [Abstract] [Full Text] [Related]

  • 33. DNA-VLP prime-boost intra-nasal immunization induces cellular and humoral anti-HIV-1 systemic and mucosal immunity with cross-clade neutralizing activity.
    Buonaguro L, Devito C, Tornesello ML, Schröder U, Wahren B, Hinkula J, Buonaguro FM.
    Vaccine; 2007 Aug 10; 25(32):5968-77. PubMed ID: 17629365
    [Abstract] [Full Text] [Related]

  • 34. A novel HBV DNA vaccine based on T cell epitopes and its potential therapeutic effect in HBV transgenic mice.
    Li X, Yang X, Jiang Y, Liu J.
    Int Immunol; 2005 Oct 10; 17(10):1293-302. PubMed ID: 16113237
    [Abstract] [Full Text] [Related]

  • 35. Prime-boost immunization using alphavirus replicon and adenovirus vectored vaccines induces enhanced immune responses against classical swine fever virus in mice.
    Zhao HP, Sun JF, Li N, Sun Y, Wang Y, Qiu HJ.
    Vet Immunol Immunopathol; 2009 Oct 15; 131(3-4):158-66. PubMed ID: 19411115
    [Abstract] [Full Text] [Related]

  • 36. Induction of protective and therapeutic antitumor immunity by a DNA vaccine with C3d as a molecular adjuvant.
    Xu GL, Zhang KQ, Guo B, Zhao TT, Yang F, Jiang M, Wang QH, Shang YH, Wu YZ.
    Vaccine; 2010 Oct 18; 28(44):7221-7. PubMed ID: 20800113
    [Abstract] [Full Text] [Related]

  • 37. Immunopreventive effects against murine H22 hepatocellular carcinoma in vivo by a DNA vaccine targeting a gastrin- releasing peptide.
    Meko'o JL, Xing Y, Zhang H, Lu Y, Wu J, Cao R.
    Asian Pac J Cancer Prev; 2014 Oct 18; 15(20):9039-43. PubMed ID: 25374249
    [Abstract] [Full Text] [Related]

  • 38. Late administration of plasmid DNA by intradermal electroporation efficiently boosts DNA-primed T and B cell responses to carcinoembryonic antigen.
    Bråve A, Hallengärd D, Gudmundsdotter L, Stout R, Walters R, Wahren B, Hallermalm K.
    Vaccine; 2009 Jun 08; 27(28):3692-6. PubMed ID: 19428161
    [Abstract] [Full Text] [Related]

  • 39. Immunisation strategies against prion diseases: prime-boost immunisation with a PrP DNA vaccine containing foreign helper T-cell epitopes does not prevent mouse scrapie.
    Nitschke C, Flechsig E, van den Brandt J, Lindner N, Lührs T, Dittmer U, Klein MA.
    Vet Microbiol; 2007 Aug 31; 123(4):367-76. PubMed ID: 17499458
    [Abstract] [Full Text] [Related]

  • 40. Immunotherapy of prostate cancer in a murine model using a novel GnRH based vaccine candidate.
    Junco JA, Peschke P, Zuna I, Ehemann V, Fuentes F, Bover E, Pimentel E, Basulto R, Reyes O, Calzada L, Castro MD, Arteaga N, López Y, Garay H, Hernández H, Bringas R, Guillén GE.
    Vaccine; 2007 Dec 05; 25(50):8460-8. PubMed ID: 18022737
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 37.